Form 8-K - Current report:
SEC Accession No. 0001213900-25-089566
Filing Date
2025-09-19
Accepted
2025-09-19 16:30:53
Documents
14
Period of Report
2025-09-19
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0258116-8k_advanced.htm   iXBRL 8-K 25918
2 PRESS RELEASE, DATED SEPTEMBER 19, 2025 ea025811601ex99-1_advanced.htm EX-99.1 13935
3 GRAPHIC ex99-1_001.jpg GRAPHIC 20071
  Complete submission text file 0001213900-25-089566.txt   239193

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE advb-20250919.xsd EX-101.SCH 3023
5 XBRL LABEL FILE advb-20250919_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE advb-20250919_pre.xml EX-101.PRE 22364
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0258116-8k_advanced_htm.xml XML 3769
Mailing Address 401 RYLAND ST STE 200-A RENO NV 89502
Business Address 401 RYLAND ST STE 200-A RENO NV 89502 86-21-20510823
Advanced Biomed Inc. (Filer) CIK: 0001941029 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV
Type: 8-K | Act: 34 | File No.: 001-42548 | Film No.: 251327232
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)